CIK: 0001534261
申報總市值
US$13.2億
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Loxo Oncology INC | 股票-其他 | 9.36% | — | — | |
| 2 | MYOKEUR | Myokardia INC | 股票-其他 | 6.78% | — | +41.77% | |
| 3 | ALNY | Alnylam Pharmaceuticals INC | 股票-醫療保健 | 6.63% | +0.03% | +90.48% | |
| 4 | SGMOQ | Sangamo Therapeutics INC | 股票-其他 | 5.93% | — | — | |
| 5 | 2655787D | Blueprint Medicines CORP | 股票-其他 | 5.86% | — | +8.36% | |
| 6 | ✓ | 股票-其他 | 5.62% | — | +123.08% | ||
| 7 | ✓ | Foundation Medicine INC | 股票-其他 | 5.45% | — | — | |
| 8 | KRG | Kite Realty Group Trust | 股票-房地產 | 5.38% | — | +17.78% | |
| 9 | ONCEEUR | Spark Therapeutics INC | 股票-其他 | 5.27% | — | +23.22% | |
| 10 | AGIO | Agios Pharmaceuticals INC | 股票-其他 | 4.81% | — | — | |
| 11 | VYGR | Voyager Therapeutics INC | 股票-其他 | 4.74% | — | +10.14% | |
| 12 | SG7 | Sage Therapeutics INC | 股票-其他 | 4.22% | — | -5.88% | |
| 13 | GNMK | Genmark Diagnostics INC | 股票-其他 | 4.08% | — | +118.98% | |
| 14 | EVH | Evolent Health INC - A | 股票-其他 | 4.00% | — | +52.88% | |
| 15 | GBTUSD | Global Blood Therapeutics In | 股票-其他 | 3.33% | — | +76.74% | |
| 16 | BOLDEUR | Audentes Therapeutics INC | 股票-其他 | 3.16% | — | — | |
| 17 | CLVSEUR | Clovis Oncology INC | 股票-其他 | 2.97% | — | -1.92% | |
| 18 | CDXS | Codexis INC | 股票-其他 | 2.77% | — | +23.95% | |
| 19 | ILMN | Illumina INC | 股票-醫療保健 | 2.47% | +0.06% | +39.68% | |
| 20 | JNCEEUR | Jounce Therapeutics INC | 股票-其他 | 1.76% | — | +149.89% | |
| 21 | T8S | Tesaro INC | 股票-其他 | 1.40% | — | -19.79% | |
| 22 | SYRSEUR | Syros Pharmaceuticals INC | 股票-其他 | 1.06% | — | +40.67% | |
| 23 | CTMX | Cytomx Therapeutics INC | 股票-其他 | 0.91% | — | — | |
| 24 | EDIT | Editas Medicine INC | 股票-其他 | 0.90% | — | — | |
| 25 | FATE | Fate Therapeutics INC | 股票-其他 | 0.61% | — | — | |
| 26 | OVID | Ovid Therapeutics INC | 股票-其他 | 0.50% | — | -6.41% |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | MYOKEUR | Myokardia INC | +4.9% | +41.77% | 加碼 |
| 2 | ALNY | Alnylam Pharmaceuticals INC | +3.5% | +90.48% | 加碼 |
| 3 | ✓ | +3.1% | +123.08% | 加碼 | |
| 4 | VYGR | Voyager Therapeutics INC | +2.3% | +10.14% | 加碼 |
| 5 | KRG | Kite Realty Group Trust | +1.9% | +17.78% | 加碼 |
| 6 | ONCEEUR | Spark Therapeutics INC | +1.5% | +23.22% | 加碼 |
| 7 | SGMOQ | Sangamo Therapeutics INC | +1.4% | — | 不變 |
| 8 | GBTUSD | Global Blood Therapeutics In | +1.2% | +76.74% | 加碼 |
| 9 | GNMK | Genmark Diagnostics INC | +1.1% | +118.98% | 加碼 |
| 10 | JNCEEUR | Jounce Therapeutics INC | +0.9% | +149.89% | 加碼 |
| 11 | 2655787D | Blueprint Medicines CORP | +0.7% | +8.36% | 加碼 |
| 12 | ILMN | Illumina INC | +0.5% | +39.68% | 加碼 |
| 13 | CDXS | Codexis INC | +0.4% | +23.95% | 加碼 |
| 14 | BOLDEUR | Audentes Therapeutics INC | +0.3% | — | 不變 |
| 15 | EDIT | Editas Medicine INC | +0.1% | — | 不變 |
| 16 | SYRSEUR | Syros Pharmaceuticals INC | 0% | +40.67% | 加碼 |
| 17 | AGIO | Agios Pharmaceuticals INC | 0% | — | 不變 |
| 18 | FATE | Fate Therapeutics INC | 0% | — | 不變 |
| 19 | CTMX | Cytomx Therapeutics INC | -0.1% | — | 不變 |
| 20 | OVID | Ovid Therapeutics INC | -0.4% | -6.41% | 減碼 |
| 21 | EVH | Evolent Health INC - A | -0.9% | +52.88% | 加碼 |
| 22 | T8S | Tesaro INC | -1.1% | -19.79% | 減碼 |
| 23 | ✓ | Loxo Oncology INC | -1.3% | — | 不變 |
| 24 | CLVSEUR | Clovis Oncology INC | -1.5% | -1.92% | 減碼 |
| 25 | ✓ | Foundation Medicine INC | -1.6% | — | 不變 |
| 26 | SG7 | Sage Therapeutics INC | -3.3% | -5.88% | 減碼 |
| 27 | XBI | Ss Spdr S&p Biotech ETF | — | EXIT | 清倉 |
| 28 | GILD | Gilead Sciences INC | — | EXIT | 清倉 |
| 29 | EPZMEUR | Epizyme INC | — | EXIT | 清倉 |
| 30 | MYGN | Myriad Genetics INC | — | EXIT | 清倉 |
| 31 | MDRX | Veradigm INC | — | EXIT | 清倉 |
| 32 | AMRSEUR | Amyris INC | — | EXIT | 清倉 |
| 33 | PACB | Pacific Biosciences Of Calif | — | EXIT | 清倉 |
| 34 | ✓ | Curis INC | — | EXIT | 清倉 |